Although 5-Amino-1MQ is still considered an emerging longevity compound, its ability to inhibit NNMT positions it as one of the most promising tools for preserving NAD+ and supporting mitochondrial health, especially when combined with NAD+ therapy
Short-term studies might use higher acute doses, while long-term studies require careful consideration of sustained exposure and potential adaptations to the 5-Amino-1MQ dosage over time
After each use, ensure the rubber stopper is clean and the cap is on, then return the vial to refrigerated storage
BPC-157 and TB-500 are not miracle drugs, but in the right hands of qualified clinicians on the right patient, these two compounds have the power to improve the healing process to a great degree
Biochemical markers of bone turnover part I: biochemistry and variability. Clin Biochem Rev , 2005
Removal from Category 2 means the FDA no longer considers BPC-157 to pose the level of safety risk that warrants this restriction